全球細胞活力檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034）

細胞活力檢測市場預計將從 2025 年的 47 億美元成長到 2034 年的 97.6 億美元，2026 年至 2034 年的複合年成長率為 8.47%。

由於藥物研發、癌症研究和再生醫學研究領域的需求不斷成長，全球細胞活力檢測市場正在快速擴張。製藥和生物技術公司高度依賴細胞活力檢測來評估細胞毒性和治療效果。生命科學研究經費的增加和臨床試驗的擴展是推動全球市場成長的重要因素。

主要促進因素包括慢性病盛行率上升、研發投入增加以及先進檢測技術的廣泛應用。向個人化醫療的轉變和生物製藥的開發進一步增加了對可靠的細胞檢測方法的需求。研究機構的自動化以及檢測靈敏度和重複性的提高也推動了這些技術的更廣泛應用。

隨著3D細胞培養模式和高通量篩檢的不斷創新，市場前景依然強勁。學術機構與製藥公司之間合作的加強有望加速產品研發。隨著新興地區生物技術生態系統的擴展，對高效、精準的細胞活力檢測解決方案的需求預計將穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球細胞活力檢測市場：依產品分類

• 市場分析、洞察與預測
• 試劑
• 裝置
• 消耗品

第5章：全球細胞活力檢測市場：依應用領域分類

• 市場分析、洞察與預測
• 藥物發現與開發
• 基礎研究
• 幹細胞研究
• 臨床和診斷
• 其他

第6章：全球細胞活力檢測市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 學術研究機構
• 受託研究機構
• 其他

第7章 全球細胞活力檢測市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Becton
  • Dickinson And Company
  • Bio-Rad Laboratories Inc
  • Promega Corporation
  • PerkinElmer Inc
  • Danaher Corporation
  • Agilent Technologies Inc
  • Abcam Plc
  • Biotium Inc
  • Creative Bioarray
  • Biotek Instruments Inc
  • Cell Biolabs Inc
  • GE Healthcare

The Cell Viability Assays Market size is expected to reach USD 9.76 Billion in 2034 from USD 4.70 Billion (2025) growing at a CAGR of 8.47% during 2026-2034.

The Global Cell Viability Assays Market is expanding rapidly due to growing demand for drug discovery, cancer research, and regenerative medicine studies. Pharmaceutical and biotechnology companies rely heavily on cell viability assays to evaluate cytotoxicity and therapeutic effectiveness. Increased funding for life sciences research and the expansion of clinical trials are contributing significantly to market growth worldwide.

Key drivers include the rising prevalence of chronic diseases, increased R&D investments, and growing adoption of advanced assay technologies. The shift toward personalized medicine and biologics development has further intensified the need for reliable cell-based testing methods. Automation in laboratories and improvements in assay sensitivity and reproducibility are also supporting broader adoption across research institutions.

The market outlook remains strong as innovation in 3D cell culture models and high-throughput screening continues to evolve. Growing collaborations between academic institutions and pharmaceutical companies are expected to boost product development. With expanding biotechnology ecosystems in emerging regions, the demand for efficient and accurate cell viability testing solutions will likely grow steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Reagents
• Instruments
• Consumables

By Application

• Drug Discovery And Development
• Basic Research
• Stem Cell Research
• Clinical And Diagnostics
• Others

By End-User

• Pharmaceutical And Biotechnology Companies
• Academic And Research Institutes
• Contract Research Organizations
• Others

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Merck KGaA, Becton, Dickinson and Company, BioRad Laboratories Inc, Promega Corporation, PerkinElmer Inc, Danaher Corporation, Agilent Technologies Inc, Abcam plc, Biotium Inc, Creative Bioarray, Biotek Instruments Inc, Cell Biolabs Inc, GE Healthcare
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CELL VIABILITY ASSAYS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CELL VIABILITY ASSAYS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Drug Discovery And Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Basic Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Stem Cell Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Clinical And Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CELL VIABILITY ASSAYS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Pharmaceutical And Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CELL VIABILITY ASSAYS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CELL VIABILITY ASSAYS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Merck KGaA
  • 9.2.3 Becton
  • 9.2.4 Dickinson And Company
  • 9.2.5 Bio-Rad Laboratories Inc
  • 9.2.6 Promega Corporation
  • 9.2.7 PerkinElmer Inc
  • 9.2.8 Danaher Corporation
  • 9.2.9 Agilent Technologies Inc
  • 9.2.10 Abcam Plc
  • 9.2.11 Biotium Inc
  • 9.2.12 Creative Bioarray
  • 9.2.13 Biotek Instruments Inc
  • 9.2.14 Cell Biolabs Inc
  • 9.2.15 GE Healthcare